A. Left ventricular hypertrophy and ischemia: Chronic kidney disease frequently induces systemic hypertension and fluid overload, which increases cardiac afterload and myocardial oxygen demand. This chronic pressure burden leads to pathological remodeling of the myocardium and compensatory thickening of the left ventricle. Consequently, reduced capillary density and impaired coronary perfusion often result in myocardial ischemia. B. Decreased incidence of atherosclerosis and heart failure: This statement is physiologically incorrect because renal impairment significantly accelerates the progression of atherosclerotic plaques due to chronic inflammation and dyslipidemia. Patients with renal failure have a much higher risk of developing congestive heart failure. The metabolic environment in uremia promotes vascular calcification rather than protecting against it. C. Enhanced cardiac contractility and reduced vascular resistance: Renal failure typically results in the activation of the renin-angiotensin-aldosterone system, which increases systemic vascular resistance rather than reducing it. Uremic toxins and electrolyte imbalances, such as hyperkalemia or hypocalcemia, generally depress myocardial contractility. Therefore, the cardiovascular system suffers from increased resistive loads and diminished pump efficiency. D. Increased risk of hypertension and hyperthyroidism: While chronic kidney disease is a primary driver of secondary hypertension through volume expansion and sodium retention, it is not a causative factor for hyperthyroidism. Patients with renal issues more commonly develop secondary hyperparathyroidism due to phosphate retention and vitamin D deficiency. Hyperthyroidism involves an overactive thyroid gland, which is an unrelated endocrine pathology.